Innovent Biologics, MicuRx file HK biotech IPOs
Hong Kong’s new biotechnology-friendly listing regime attracted IPO filings this week from China-based Innovent Biologics and MicuRx Pharmaceuticals.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: